YAP augments PD-L1 expression in EGFR inhibitor-resistant lung cancer [73,74], pancreatic cancer [75], mesothelioma [76] and BRAF inhibitor-resistant melanoma [77]. The gene discussed is CD274; the disease is lung cancer.